4//SEC Filing
Floyd Robert Michael 4
Accession 0001567619-22-008367
CIK 0001533743other
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 5:56 PM ET
Size
5.9 KB
Accession
0001567619-22-008367
Insider Transaction Report
Form 4
Floyd Robert Michael
Chief Operating Officer
Transactions
- Award
Restricted Stock Units
2022-04-01+247,841→ 302,766 totalExercise: $0.00→ Common Stock (247,841 underlying)
Footnotes (2)
- [F1]Restricted Stock Units (RSUs) vest upon achievement of certain performance goals. The grant of 136,632 RSUs are subject to shareholder approval of the Issuer's 2019 Omnibus Incentive Plan (the "Plan") to increase the authorized shares under the Plan.
- [F2]The previous filing understated this number. This new total accurately reflects the cumulative total of Restricted Stock Units for the reporting person.
Documents
Issuer
Processa Pharmaceuticals, Inc.
CIK 0001533743
Entity typeother
Related Parties
1- filerCIK 0001828217
Filing Metadata
- Form type
- 4
- Filed
- Apr 10, 8:00 PM ET
- Accepted
- Apr 11, 5:56 PM ET
- Size
- 5.9 KB